GMO Fund Family Report
 | 

  • Select a Fund Family

    • Performance
    04-30-13

    Total ReturnCategory Average
    Total Return28.6910.80-1.0313.197.72
    Category Average36.8712.84-7.4015.246.97
    Assets for Each Yr*64.9472.0968.4783.0692.17
    *billions

    Trailing Returns %
    04-30-13

      YTD 3 Year 5 Year    
    Fund Family 7.72 9.48 3.93

    Key Stats
    04-30-13

    Total Assets* Min. Investment Load (% of Assets) No Load (% of Assets)
    $92,172 mil $10,000,000 0.00 100.00
    Asset Class Score % of Assets Expense Ratio % Expense Rating
    Domestic Stock 3.3 25.28 0.41 Very Low
    International Stock 3.6 45.99 0.69 Very Low
    Municipal Bond -- -- -- --
    Taxable Bond 2.7 9.13 0.34 Very Low
    *Doesn't include money market assets.

    Top 20 US Holdings | Get Price Quotes
    05-17-13

      Sector YTD Return % % Net Assets  
    Johnson & Johnson* Healthcare 26.53 1.02
    Google, Inc. Class A* Technology 28.53 0.97
    Oracle Corporation* Technology 5.13 0.97
    Coca-Cola Co* Consumer Defensive 19.31 0.91
    Cisco Systems Inc* Technology 24.23 0.85
    Microsoft Corporation* Technology 32.27 0.83
    Pfizer Inc* Healthcare 17.39 0.83
    Philip Morris International, Inc* Consumer Defensive 15.41 0.74
    Chevron Corp* Energy 15.89 0.69
    Procter & Gamble Co* Consumer Defensive 19.58 0.64
    Express Scripts* Healthcare 14.57 0.61
    International Business Machines * Technology 9.76 0.60
    Hewlett-Packard Co* Technology 50.19 0.59
    PepsiCo Inc* Consumer Defensive 23.25 0.58
    Wal-Mart Stores Inc* Consumer Cyclical 15.51 0.57
    Colgate-Palmolive Company* Consumer Defensive 19.93 0.49
    McDonald's Corporation* Consumer Cyclical 15.98 0.42
    Apple Inc* Technology -17.52 0.42
    Target Corp* Consumer Defensive 21.31 0.41
    MasterCard Incorporated Class A* Financial Services 19.22 0.28

    Best 5-Year Relative Performance | More
    05-17-13

    Fund Name 5-Yr Rank Analyst Report  
    GMO Benchmark-Free Allocatio 1 --
    GMO Quality III 3 03-12-13
    GMO US Growth III 3 --
    GMO Emerging Country Debt II 4 05-18-11
    GMO US Equity Allocation III 4 --

    Worst 5-Year Relative Performance | More
    05-17-13

    Fund Name 5-Yr Rank Analyst Report  
    GMO Emerging Countries III 82 --
    GMO Strategic Fixed Income V 77 --
    GMO Emerging Markets III 73 10-08-12
    GMO Developed World Stock II 64 --
    GMO International Bond III 63 --

    Lowest Expenses | More
    05-17-13

    Fund Name Expense Ratio Analyst Report  
    GMO Global Asset Allocation 0.00 08-21-12
    GMO Global Equity Allocation 0.00 --
    GMO International Equity All 0.00 --
    GMO International Opp Equity 0.00 --
    GMO Strategic Opportunities 0.00 --

    Highest Expenses | More
    05-17-13

    Fund Name Expense Ratio Analyst Report  
    GMO Taiwan III 1.38 --
    GMO Emerging Countries III 1.18 --
    GMO Emerging Markets III 1.01 10-08-12
    GMO Foreign Small Companies 0.85 --
    GMO Global Focused Equity II 0.83 --

    Longest Manager Tenure | More
    05-17-13

    Fund Name   Manager Name Avg Manager Tenure  
    GMO International Bo Thomas F. Cooper 19.40
    GMO Emerging Country Thomas F. Cooper 19.10
    GMO Domestic Bond II Thomas F. Cooper 18.70
    GMO Currency Hedged Thomas F. Cooper 18.60
    GMO Global Bond III Thomas F. Cooper 17.40

    Shortest Manager Tenure | More
    05-17-13

    Fund Name   Manager Name Avg Manager Tenure  
    GMO Risk Premium VI David Cowan 0.50
    GMO Global Asset All Ben Inker 0.70
    GMO Global Equity Al Ben Inker 0.70
    GMO International Eq Ben Inker 0.90
    GMO Intl Intrinsic V Thomas Hancock 0.90